Navigation Links
United Kingdom Is Lagging In Novelty In The Field Of Pharmaceuticals

United Kingdom is lagging in innovation, as shown by the market share of new medicines in various countries, including primary care and hospital markets. Reports from various sources prove that Europe has shown very low growth in the field of pharmaceuticals and hospital care//.

Europe has a new plan in order to counter the worsening competitive position of its biopharmaceutical enterprises. The policy is nominally based on a report submitted by Boston based international consultancy Charles River Associates (CRA) to the European Commission to investigate the status and reasons for Europe’s decline in Pharma industry.

Although the US market experienced similar landslides it has been able to grow to higher proportion in the field of new biologics. This is not happening in the case of Europe. “The decline is real and is likely to get worse,” noted independent biotech consultant David Glover, former research director of Cambridge Antibody Technology. Many young European firms, he said, are becoming disillusioned with the lack of reward for innovation.

European Commission Vice president Gunter Verheugen has announced a policy for referendum of the Europe’s biotech policy. The first aspect would be to double the financial support for life sciences research, taken from the six year, $132 billion Research Framework program that begins in 2007. The second aspect would be greasing the wheels of safety and efficacy testing for new types of medicines. The third policy would be to resolving a patchwork of different national systems for drug pricing, which” place a significant burden on industry and can delay access to the market.” The last policy of restricting on patients access to information on new medicines are to be considered.

Verheugen is confident that the program will deliver some concrete results within three years.

Source: Nature Biotechnoogy
'"/>




Page: 1

Related medicine news :

1. Scientists plan human cloning clinic in the United States
2. GlaxoSmithKline to Supply United States with 8 Million flu vaccine, Fluarix
3. United Kingdom to perform its first Live Liver Transplant
4. Inhospitable Response Curtail Growth Of Specialty Hospitals: United States
5. United Kingdom: Farmers Cautioned To Plan Adequately For Bird-Flu
6. Bird-Flu Causes Alarm in United Kingdom.
7. 2010 AIDS Target May Misfire, Warns United Nations
8. AIDS Meet Ends Without Firm Commitments From Donors Dharam Shourie United Nations
9. United Nations draws flak Due to Lukewarm AIDS Prevention Measures
10. Chinese Poultry Smuggled into United States
11. United Kingdom: Making the most of sunshine without the cream
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/2/2016)... Raleigh, NC (PRWEB) , ... December 02, 2016 , ... ... the Open Enrollment Period (or Annual Election Period), is ending December 7th. Currently-enrolled Medicare ... plan (Part C) or prescription drug plan (Part D) need to make changes during ...
(Date:12/2/2016)... (PRWEB) , ... December 02, 2016 , ... ... inspirational interview of two ostomy patients, standing as living proof that attitude and ... from digestive diseases and issues that spike around the holidays. This campaign will ...
(Date:12/2/2016)... , ... December 02, 2016 , ... ... of "Cardiovascular Health" in USA Today, which covers the innovative treatments, therapeutic technologies, ... while maintaining fulfilling lives. “We are prolonging life 6 years in the last ...
(Date:12/2/2016)... OH (PRWEB) , ... December 02, 2016 , ... ... of veterinarian diagnostic imaging systems and the first company to offer ... With a Heart at their tradeshow booth # 941 for the American Association ...
(Date:12/2/2016)... ... 02, 2016 , ... Yisrayl Hawkins, at The House of Yahweh in Abilene, ... into Bible Prophecy. Yisrayl says this generation, known as the Last Generation, started in ... the details line up exactly with Bible Prophecy – a protected way for those ...
Breaking Medicine News(10 mins):
(Date:12/2/2016)... , Dec. 1, 2016  Today, Simpson Healthcare Executives, ... honor of being selected as winners of multiple awards ... Executives Website at the PLATINUM level, Blue Zones Menu ... at the GOLD Level, and our proprietary 3ConneX Platform ... Simpson Healthcare Executives, we are excited to showcase our ...
(Date:12/2/2016)... BRUSSELS , Dec. 2, 2016  UCB is pleased to ... presentation at the upcoming 70 th American Epilepsy Society ... Houston, TX , USA. 1-12 ... safety and efficacy profile of VIMPAT ® (lacosamide) CV ... also share findings on the current state of the union ...
(Date:12/2/2016)... Dec. 2, 2016 Allergan plc (NYSE: ... information on its previously announced Accelerated Share Repurchase (ASR) Program. ... ... As previously announced, the Company entered into a ... the Company will repurchase $10 billion of its ordinary shares. ...
Breaking Medicine Technology: